While some suggest a correlation between high KLRB1 expression in tumors and poorer patient prognosis, others propose that KLRB1 may enhance the anti-tumor capabilities of immune cells, potentially improving patient outcomes [15–18]. Here, KLRB1 is linked to neoplasm.